Project Grant R35GM163544
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The University of Texas Health Science Center at San Antonio a $378,000 Project Grant effective May 1, 2026, through April 30, 2031, under the Biomedical Research and Research Training program (CFDA 93.859). This five-year project funds fundamental research investigating how intrinsically disordered proteins and intrinsically disordered regions regulate critical nuclear processes including...
- Federal Project Grant Award Summary Texas State University received a $148,228 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 15, 2025 through June 30, 2029. The award funds fundamental biochemical research investigating the mechanism of protein sumoylation mediated by the SMC5/6 complex in DNA repair pathways. The research addresses a critical gap in understanding how...
- Federal Project Grant Award Summary Baylor College of Medicine received a $516,608 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2030. The award supports fundamental research on the mechanisms and regulation of DNA recombination, with a focus on understanding how double-strand breaks (DSBs) are repaired through homologous recombination and...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $404,569 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. This award supports fundamental biomedical research investigating Z-DNA (left-handed DNA conformation) and its role in regulating RNA Polymerase III transcription. The research deliverables...
- Federal Grant Award Summary The University of Texas Health Science Center at San Antonio received a $385,639 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. The award funds basic biomedical research investigating the molecular architecture and function of synaptic AMPA (A-amino-3-hydroxy-5-methyl-4-isoxazolepropionic) receptor complexes. The...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The University of Texas Southwestern Medical Center a Project Grant totaling $2,233,277 under the Biomedical Research and Research Training program (CFDA 93.859) to support a five-year research initiative investigating the catalytic mechanisms, regulation, and drug-target potential of bacterial alarmone hydrolases. Award Date: September 3, 2025; Ultimate Completion Date: August 31, 2029. The research...
- Federal Project Grant Award Summary The University of Texas at Arlington received a $412,433 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026 through January 31, 2031. This award funds investigator-initiated fundamental research into bacterial stress response mechanisms, specifically examining how the second messenger cyclic di-AMP (c-di-AMP) regulates bacterial...
- Federal Project Grant Award Summary The University of Texas at Austin received a $385,065 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 15, 2025, through August 31, 2030. This award supports fundamental research utilizing cryo-electron microscopy (cryo-EM) to elucidate the structure and function of macromolecular machines involved in gene regulation. The primary research...
- Federal Project Grant Award Summary The University of Texas Health Science Center at Houston received a $390,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through June 30, 2030. This award funds fundamental biomedical research investigating tissue-specific regulation of autophagy by proppins (B-propellers that bind phosphoinositides), with the objective...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $449,900 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded May 1, 2026, with completion targeted for April 30, 2028. This exploratory research project will develop novel methods for detecting and quantifying multi-site protein phosphorylation—a critical post-translational modification...
The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $433,125 to The University of Texas Health Science Center at San Antonio, effective June 1, 2026, through January 31, 2031, under the Biomedical Research and Research Training program (CFDA 93.859). This award funds research on the spatiotemporal regulation of DNA metabolism pathways, specifically investigating how homologous recombination (HR) proteins are dynamically regulated to repair DNA double-stranded breaks (DSBs) while maintaining their distinct functions at other DNA structures such as stalled replication forks, centromeres, and telomeres. The research addresses a critical knowledge gap regarding how HR protein activity is selectively activated and deactivated, with particular focus on tyrosine phosphorylation and dephosphorylation as regulatory mechanisms. The project deliverables include fundamental research findings that advance understanding of genomic stability mechanisms and the pathways underlying DNA damage repair processes. By elucidating the regulatory mechanisms that control HR protein function, this research aims to provide scientific insights relevant to preventing pathologies such as meiotic defects, infertility, developmental syndromes, and cancer that can result from defective homologous recombination. The research will be conducted at UTHSCSA's facilities in San Antonio, Texas, leveraging the institution's established expertise in biomedical research and its track record of successful NIH-funded investigations.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $433.1k | 5/7/26 |